IMPROVED RESULTS: Genoa Healthcare General Manager Andrew Terranova says providing buprenorphine treatment for patients at pharmacies can improve substance use disorder outcomes. PBN PHOTO/MICHAEL SALERNO
Andrew Terranova, a pharmacist and general manager at Genoa Healthcare in Providence, was optimistic when his pharmacy signed onto a study intended to create new pathways for opioid use disorder treatment. Instead of starting at a doctor’s office or clinic, the study, led by researchers at Brown University and the University of Rhode Island, allowed…
You must be a paid subscriber to read this content.
To keep reading and receive unlimited access subscribe today for only $1.
Subscribe NowAlready a Subscriber?
Login now
Want to share this story? Click Here to purchase a link that allows anyone to read it on any device whether or not they are a subscriber.
Want to share this story? Click Here to purchase a link that allows anyone to read it on any device whether or not they are a subscriber.
